{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T03:47:34Z","timestamp":1782100054535,"version":"3.54.5"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s00210-026-05026-0","type":"journal-article","created":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T02:12:10Z","timestamp":1769566330000},"page":"9955-9968","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Paeoniflorigenone inhibits the progression of cholangiocarcinoma via HIF1A and enhances the chemotherapy sensitivity of cisplatin"],"prefix":"10.1007","volume":"399","author":[{"given":"Qing","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengqin","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feicheng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengjun","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhou","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanchun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,28]]},"reference":[{"issue":"2","key":"5026_CR1","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1007\/s12013-024-01578-1","volume":"83","author":"Y An","year":"2024","unstructured":"An Y, Xu J, Hu X et al (2024) GBP2 regulates lipid metabolism by inhibiting the HIF-1 pathway to alleviate the progression of allergic rhinitis. Cell Biochem Biophys 83(2):1689\u20131701","journal-title":"Cell Biochem Biophys"},{"key":"5026_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/cells10071715","author":"MH-R Bao","year":"2021","unstructured":"Bao MH-R, Wong CC-L (2021) Hypoxia, metabolic reprogramming, and drug resistance in liver cancer. Cells. https:\/\/doi.org\/10.3390\/cells10071715","journal-title":"Cells"},{"issue":"1","key":"5026_CR3","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1186\/1471-2105-15-293","volume":"15","author":"P Bardou","year":"2014","unstructured":"Bardou P, Mariette J, ESCUDI\u00e9 F et al (2014) jvenn: an interactive Venn diagram viewer. BMC Bioinformatics 15(1):293","journal-title":"BMC Bioinformatics"},{"issue":"1","key":"5026_CR4","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/s41572-021-00300-2","volume":"7","author":"PJ Brindley","year":"2021","unstructured":"Brindley PJ, Bachini M, Ilyas SI et al (2021) Cholangiocarcinoma. Nat Rev Dis Primers 7(1):65","journal-title":"Nat Rev Dis Primers"},{"issue":"5","key":"5026_CR5","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s13402-020-00534-4","volume":"43","author":"B Chen","year":"2020","unstructured":"Chen B, Li L, Li M et al (2020) HIF1A expression correlates with increased tumor immune and stromal signatures and aggressive phenotypes in human cancers. Cell Oncol (Dordr) 43(5):877\u2013888","journal-title":"Cell Oncol (Dordr)"},{"issue":"1","key":"5026_CR6","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1186\/s13046-023-02842-7","volume":"42","author":"Y Chen","year":"2023","unstructured":"Chen Y, Xu X, Wang Y et al (2023) Hypoxia-induced SKA3 promoted cholangiocarcinoma progression and chemoresistance by enhancing fatty acid synthesis via the regulation of PAR-dependent HIF-1a deubiquitylation. J Exp Clin Cancer Res 42(1):265","journal-title":"J Exp Clin Cancer Res"},{"issue":"8","key":"5026_CR7","doi-asserted-by":"publisher","first-page":"5789","DOI":"10.1007\/s00210-024-02985-0","volume":"397","author":"X Chen","year":"2024","unstructured":"Chen X, Sun B, Zeng J et al (2024) Molecular mechanism of Spatholobi caulis treatment for cholangiocarcinoma based on network pharmacology, molecular docking, and molecular dynamics simulation. Naunyn Schmiedebergs Arch Pharmacol 397(8):5789\u20135806","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"1","key":"5026_CR8","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.trecan.2021.10.004","volume":"8","author":"SJ Cowman","year":"2021","unstructured":"Cowman SJ, Koh MY (2021) Revisiting the HIF switch in the tumor and its immune microenvironment. Trends Cancer 8(1):28\u201342","journal-title":"Trends Cancer"},{"key":"5026_CR9","doi-asserted-by":"publisher","DOI":"10.1097\/hep.0000000000000544","author":"J Edeline","year":"2023","unstructured":"Edeline J, Bridgewater J, Campillo-Gimenez B et al (2023) Chemotherapy with or without selective internal radiation therapy for intrahepatic cholangiocarcinoma: data from clinical trials. Hepatology. https:\/\/doi.org\/10.1097\/hep.0000000000000544","journal-title":"Hepatology"},{"issue":"3","key":"5026_CR10","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.ajpath.2024.11.005","volume":"195","author":"H Ellis","year":"2024","unstructured":"Ellis H, Braconi C, Valle JW et al (2024) Cholangiocarcinoma targeted therapies: mechanisms of action and resistance [J]. Am J Pathol 195(3):437\u2013452","journal-title":"Am J Pathol"},{"key":"5026_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24065920","author":"E Gentilin","year":"2023","unstructured":"Gentilin E (2023) New advancements in cisplatin-based treatments. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms24065920","journal-title":"Int J Mol Sci"},{"issue":"6","key":"5026_CR12","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41575-022-00741-4","volume":"20","author":"TF Greten","year":"2023","unstructured":"Greten TF, Schwabe R, Bardeesy N et al (2023) Immunology and immunotherapy of cholangiocarcinoma. Nat Rev Gastroenterol Hepatol 20(6):349\u2013365","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"5","key":"5026_CR13","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1111\/cas.13990","volume":"110","author":"Y Hayashi","year":"2019","unstructured":"Hayashi Y, Yokota A, Harada H et al (2019) Hypoxia\/pseudohypoxia-mediated activation of hypoxia-inducible factor-1\u03b1 in cancer [J]. Cancer Sci 110(5):1510\u20131517","journal-title":"Cancer Sci"},{"issue":"6","key":"5026_CR14","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1080\/09168451.2017.1300517","volume":"81","author":"Y Huang","year":"2017","unstructured":"Huang Y, Ohno O, Suenaga K et al (2017) Apoptosis-inducing activity and antiproliferative effect of Paeoniflorigenone from Moutan cortex. Biosci Biotechnol Biochem 81(6):1106\u20131113","journal-title":"Biosci Biotechnol Biochem"},{"issue":"2","key":"5026_CR15","doi-asserted-by":"publisher","first-page":"113","DOI":"10.2174\/0115665232301727240422092311","volume":"25","author":"F Jalali-Zefrei","year":"2025","unstructured":"Jalali-Zefrei F, Mousavi SM, Delpasand K et al (2025) Role of non-coding RNAs on the radiotherapy sensitivity and resistance in cancer cells. Curr Gene Ther 25(2):113\u2013135","journal-title":"Curr Gene Ther"},{"issue":"1","key":"5026_CR16","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1080\/14728222.2022.2029412","volume":"26","author":"LA Kankeu Fonkoua","year":"2022","unstructured":"Kankeu Fonkoua LA, Serrano Uson Junior PL, Mody K et al (2022) Novel and emerging targets for cholangiocarcinoma progression: therapeutic implications. Expert Opin Ther Targets 26(1):79\u201392","journal-title":"Expert Opin Ther Targets"},{"issue":"7","key":"5026_CR17","doi-asserted-by":"publisher","first-page":"473","DOI":"10.2174\/0113894501294182240401060343","volume":"25","author":"Q Li","year":"2024","unstructured":"Li Q, Chen S, Wang X et al (2024) Cisplatin-based combination therapy for enhanced cancer treatment. Curr Drug Targets 25(7):473\u2013491","journal-title":"Curr Drug Targets"},{"issue":"1","key":"5026_CR18","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12943-024-02213-6","volume":"24","author":"S Li","year":"2025","unstructured":"Li S, Chen X, Shi H et al (2025) Tailoring traditional Chinese medicine in cancer therapy. Mol Cancer 24(1):27","journal-title":"Mol Cancer"},{"issue":"3","key":"5026_CR19","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1080\/15376516.2024.2411621","volume":"35","author":"X Liang","year":"2024","unstructured":"Liang X, Yang H, Hu P et al (2024) Decoding the possible mechanism of action of Paeoniflorigenone in combating aflatoxin B1-induced liver cancer: an investigation using network pharmacology and bioinformatics analysis. Toxicol Mech Methods 35(3):292\u2013304","journal-title":"Toxicol Mech Methods"},{"issue":"45","key":"5026_CR20","doi-asserted-by":"publisher","first-page":"6893","DOI":"10.1038\/s41388-020-01474-x","volume":"39","author":"Y Liu","year":"2020","unstructured":"Liu Y, Wang X, Li W et al (2020) Oroxylin A reverses hypoxia-induced cisplatin resistance through inhibiting HIF-1\u03b1 mediated XPC transcription. Oncogene 39(45):6893\u20136905","journal-title":"Oncogene"},{"key":"5026_CR21","doi-asserted-by":"crossref","unstructured":"Liu Q, Jiang L, Zhao Y et al (2024) Paeoniflorigenone inhibits ovarian cancer metastasis through targeting the MUC1\/Wnt\/\u03b2\u2011catenin pathway. Int J Mol Med 54(1):60","DOI":"10.3892\/ijmm.2024.5384"},{"issue":"4","key":"5026_CR22","doi-asserted-by":"publisher","first-page":"379","DOI":"10.5582\/bst.2025.01233","volume":"19","author":"S Liu","year":"2025","unstructured":"Liu S, Jiang J, Jian Q et al (2025) Chinese multicenter expert consensus on the diagnosis and treatment of hilar cholangiocarcinoma: 2025 edition. Biosci Trends 19(4):379\u2013403","journal-title":"Biosci Trends"},{"issue":"2","key":"5026_CR23","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.tips.2021.11.004","volume":"43","author":"C Nogales","year":"2021","unstructured":"Nogales C, Mamdouh ZM, List M et al (2021) Network pharmacology: curing causal mechanisms instead of treating symptoms. Trends Pharmacol Sci 43(2):136\u2013150","journal-title":"Trends Pharmacol Sci"},{"issue":"3","key":"5026_CR24","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41571-018-0142-8","volume":"16","author":"JS O'donnell","year":"2019","unstructured":"O\u2019donnell JS, Teng MWL, Smyth MJ (2019) Cancer immunoediting and resistance to T cell-based immunotherapy. Nat Rev Clin Oncol 16(3):151\u2013167","journal-title":"Nat Rev Clin Oncol"},{"issue":"2","key":"5026_CR25","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1002\/cncr.34541","volume":"129","author":"KC Ohaegbulam","year":"2022","unstructured":"Ohaegbulam KC, Koethe Y, Fung A et al (2022) The multidisciplinary management of cholangiocarcinoma. Cancer 129(2):184\u2013214","journal-title":"Cancer"},{"key":"5026_CR26","doi-asserted-by":"crossref","unstructured":"Park K-R, Lee H, Kim SH et al (2022) Paeoniflorigenone regulates apoptosis, autophagy, and necroptosis to induce anti-cancer bioactivities in human head and neck squamous cell carcinomas. J Ethnopharmacol 288:115000","DOI":"10.1016\/j.jep.2022.115000"},{"issue":"4 Pt A","key":"5026_CR27","first-page":"684","volume":"46","author":"K Rangarajan","year":"2019","unstructured":"Rangarajan K, Simmons G, Manas D et al (2019) Systemic adjuvant chemotherapy for cholangiocarcinoma surgery: a systematic review and meta-analysis. Eur J Surg Oncol 46(4 Pt A):684\u2013693","journal-title":"Eur J Surg Oncol"},{"key":"5026_CR28","doi-asserted-by":"publisher","first-page":"145796","DOI":"10.1016\/j.gene.2021.145796","volume":"798","author":"M Rashid","year":"2021","unstructured":"Rashid M, Zadeh LR, Baradaran B et al (2021) Up-down regulation of HIF-1\u03b1 in cancer progression. Gene 798:145796","journal-title":"Gene"},{"key":"5026_CR29","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1146\/annurev-pathol-030220-020455","volume":"16","author":"PM Rodrigues","year":"2020","unstructured":"Rodrigues PM, Olaizola P, Paiva NA et al (2020) Pathogenesis of cholangiocarcinoma. Annu Rev Pathol 16:433\u2013463","journal-title":"Annu Rev Pathol"},{"key":"5026_CR30","doi-asserted-by":"crossref","unstructured":"Song CW, Kim H, Kim M-S et al (2024) Role of HIF-1\u03b1 in the responses of tumors to radiotherapy and chemotherapy. Cancer Res Treat 57(1):1-10","DOI":"10.4143\/crt.2024.255"},{"issue":"9654","key":"5026_CR31","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1016\/S0140-6736(08)61354-9","volume":"372","author":"JL Tang","year":"2008","unstructured":"Tang JL, Liu BY, Ma KW (2008) Traditional Chinese medicine. Lancet 372(9654):1938\u20131940","journal-title":"Lancet"},{"issue":"1","key":"5026_CR32","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s13045-022-01292-6","volume":"15","author":"Q Wu","year":"2022","unstructured":"Wu Q, You L, Nepovimova E et al (2022) Hypoxia-inducible factors: master regulators of hypoxic tumor immune escape. J Hematol Oncol 15(1):77","journal-title":"J Hematol Oncol"},{"issue":"1","key":"5026_CR33","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s12943-024-02136-2","volume":"23","author":"J Wu","year":"2024","unstructured":"Wu J, Tang G, Cheng C-S et al (2024) Traditional Chinese medicine for the treatment of cancers of hepatobiliary system: from clinical evidence to drug discovery. Mol Cancer 23(1):218","journal-title":"Mol Cancer"},{"key":"5026_CR34","doi-asserted-by":"publisher","first-page":"910950","DOI":"10.3389\/fmolb.2022.910950","volume":"9","author":"B Zhang","year":"2022","unstructured":"Zhang B, Hu Q, Li Y et al (2022) Diaphanous-related formin subfamily: novel prognostic biomarkers and tumor microenvironment regulators for pancreatic adenocarcinoma [J]. Front Mol Biosci 9:910950","journal-title":"Front Mol Biosci"},{"key":"5026_CR35","doi-asserted-by":"crossref","unstructured":"Zhang P, Zhang D, Zhou W et al (2023) Network pharmacology: towards the artificial intelligence-based precision traditional Chinese medicine. Brief Bioinform 25(1):bbad518","DOI":"10.1093\/bib\/bbad518"},{"key":"5026_CR36","doi-asserted-by":"publisher","first-page":"116306","DOI":"10.1016\/j.jep.2023.116306","volume":"309","author":"L Zhao","year":"2023","unstructured":"Zhao L, Zhang H, Li N et al (2023) Network pharmacology, a promising approach to reveal the pharmacology mechanism of Chinese medicine formula. J Ethnopharmacol 309:116306","journal-title":"J Ethnopharmacol"},{"issue":"10","key":"5026_CR37","doi-asserted-by":"publisher","first-page":"759","DOI":"10.2174\/0109298665333926240927074528","volume":"31","author":"H Zhong","year":"2024","unstructured":"Zhong H, Liu H, Fu Q (2024) Ferroptosis as a therapeutic target in neurodegenerative diseases: exploring the mechanisms and potential of treating Alzheimer\u2019s disease and Parkinson\u2019s disease. Protein Pept Lett 31(10):759\u2013772","journal-title":"Protein Pept Lett"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05026-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05026-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05026-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T02:53:48Z","timestamp":1782096828000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-026-05026-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,28]]},"references-count":37,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["5026"],"URL":"https:\/\/doi.org\/10.1007\/s00210-026-05026-0","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,28]]},"assertion":[{"value":"29 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The animal experiments in this study were approved by the Ethics Committee of Hunan Provincial People\u2019s Hospital (The First Affiliated Hospital of Hunan Normal University) and followed the standards in the Guide for the Care and Use of Laboratory Animals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}